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ABSTRACT 
OBJECTIVE: To assess health-related quality of life and co-morbidity pattern in hemodialysis patients 
METHODS: By a non probability purposive sampling procedure, 123 hemodialysis patients from our 
hemodialysis center in Sir Ganga Ram Hospital Lahore, (Pakistan) were interviewed by resident doctor 
according to the SF-36 Scales. The means and standard deviations for each of eight scales were calculated, each 
domain ranges from 0-100, the highest scores indicating better quality of life. Comorbidities like DM, 
Hypertension ,ischemic heart disease lung disease etc were also recorded. RESULTS: The scores of the eight 
scales in the hemodialysis patients were 49.92 ±30.90, 38.82 ±41.39, 46.73 ±26.54, 40.52 ± 21.65, 43.98 ±21.82, 
49.43 ±27.76, 49.85 ±40.59 and 59.93 ±17.36. Co-morbidities pattern were hypertension in 104(84.6%),DM 
59(48%),ischemic heart disease 23(18.7%) and other co morbidities were less common. The scores of most of 
the scale in the patients with co morbidities were lower as compared to patients without co morbidities. Data 
obtained was entered by a doctor in SPSS version 20 and was analyzed to compute descriptive statistics of the 
numerical variables while frequencies and their percentages for categorical variables of the study.  
CONCLUSION: The results of our study indicate that quality of life was poor among patients on hemodialysis 
particularly those having co-morbidities. Hypertension and diabetes were major co-morbidities in our study. 
Quality of life score was lower in female patients than that of male patients. Proper management of co-
morbidities can improve quality of life of these patients which will decrease disease morbidity and mortality. 
This will also provide psychological and financial relief to the suffering families and also be cost effective for 
hospital authorities in terms of availability of space.  
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Introduction 
Prolonged survival and related clinical outcomes, the functioning and well-being which define end-stage renal 
disease population is an important component of the effective medical therapy. Current developments in history 
of medical sciences such as “Chronic dialysis, peritoneal dialysis and kidney transplantation” are major 
achievement in practice of Nephrology and they have contributed to improve life expectancy in such patients. 
 In today’s medical services Patients' functional status, improved physical and mental performance and increased 
level of Satisfaction of these services beside expenditures involved in medical care defines quality of medical 
care in any society. (1). 
The hospital staff should clearly realize importance of these factors and to individualize and support the patients 
(2).  
It is difficult to define quality of life as it is related with different dimensions like physical health, mental health, 
satisfaction, interpersonal relationships, socioeconomic & residential status for their survival beyond 
expectations.(3) 
Patients having chronic ailments like ESRD in which disease cure is not a real objective of the treating 
physician, where functioning and well being of the patient is ultimate goal of medical therapy. In patients with 
chronic kidney disease quality of life can not only be generalized with increased rate of survival but also implies 
the importance of quality of survival in suffering patients.  (3,4). 
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Patients on hemodialysis who undergo dialysis sessions at regular basis generally exhibit poor quality of life, 
particularly in developing countries. (5) 
The SF36, an established and a well-recognized, scoring system to ascertain quality of life which has 8 different 
independent domains with two summary component being used all over the world and has already been 
validated. It contains both disease specific and general components which reflect the patient’s perceptions and 
viewpoints. The eight domains of this instrument includes physical function , role emotional, role physical  
emotional wellbeing, vitality, body pain, general health and social function . The score ranges from 0- 100 of 
every domain.(6) 
The higher score shows better quality of each component which is target of dialysis treatment in our routine 
practice. A change of five in each domain is practically and clinically important and impact medical care. [4,7] 
.The years of quality survival and QOL of patients with chronic non-communicable diseases like ESRD is still 
rising in developing countries(8).  
Most of the data on this topic comes from developed western countries where patients have quality healthcare 
facilities and no financial limitations whereas in developing countries there is scarcity of the data on this hot 
issue. This study was done at Sir Ganga Ram Hospital Lahore. The present study describes the quality of life 
scores measured in patients undergoing hemodialysis at our hospital and their comorbidities pattern by using the 
SF 36-item questionnaire.  
 
Subjects and Methods: 
 All the subjects were explained and informed consent was taken. The questionnaire KDQOL-SF36 was used 
and patients on maintenance hemodialysis for more than three months were interviewed by a resident doctor 
according to the questionnaire. We included patients on dialysis aged more than 18 years who had to undergo 
regularly hemodialysis with frequency of 2 – 3 times per week for more than 3 months duration who were able 
to understand local language urdu, Punjabi or other local languages. Patients were excluded if they had any 
history of malignancies confirmed from their medical records, multiple organ system dysfunction assessed 
clinically on history and record, those having difficulty in hearing and those who had undergone any major 
surgery in previous three months.  
All the subjects (123) were enrolled from Department of Nephrology Sir Ganga Ram Hospital Lahore, Pakistan. 
Strict adherence to the inclusion and exclusion criteria was ensured to maintain quality control procedure. After 
registration, interviewing doctor asked relevant questions to document socio demographic distribution and 
clinical variables of the study were obtained directly from patients or from their medical records. The variables 
specifically, co morbidities like hypertension, diabetes, ischemic heart disease, lung diseases, peripheral vascular 
disease, renal stone disease, duration on hemodialysis, Hemoglobin, serum albumin and calcium and phosphate 
were recorded in the study.  
Data obtained was entered by a doctor in SPSS version 20 and was analyzed to compute descriptive 
statistics of the numerical variables while frequencies and their percentages for categorical variables of the study. 
Cross-tabulation was done to see the impact of categorical variables and independent sample t test for numerical 
variable. 
 
Results 
A total of 123 patients participated in the study among them 61 were male and 62 were females. Their mean age 
was 50.2 ± 14.7.  
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Figure No. 1 Gender distribution 
(n=123) 
 
Co morbidities pattern of study population is given in table one. Co-morbidities pattern were hypertension in 
104(84.6%),DM 59(48%),ischemic heart disease 23(18.7%) and other co morbidities were less common. Quality 
of life scores of total population and patients with comorbidities are summarised in table 2 .The hypertensive and 
diabetic population has lower scores than non hypertensive and nondiabetic patients. The female patients 
reported lower QOL scores in all domains except role emotional. 
Other demographic and laboratory parameters have shown that frequency of dialysis were twice in 56(45.5%) 
and thrice in 67(54.5%) per week. Mean duration of dialysis was 31.20±39.52 months, mean dry weight 
58.14±13.76 kg, mean hemoglobin was 9.47±1.87g/dl, serum albumin 3.86±0.77 g/dl, serum creatinine 
9.54±3.32 mg/dl, Blood urea nitrogen 60.43± 19.45 mg/dl, serum calcium 8.41±0.96 mg/dl, and serum Po4 was 
7.81±5.73 mg/dl .Phosphorus and hemoglobin was poorly managed in our patients. 
We applied the multiple linear stepwise regression model of Physical Component Summary to know the various 
factors affecting the quality of life the four variables of age, sex, hemoglobin, and diabetes mellitus were 
variables having significant impact  (P<0.01), while in that of Mental Component Summary, the two variables of 
age and hemoglobin were significant predictors of quality of life  (P<0.01) . 
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Table NO. 1 Pattern of co-morbidities of hemodialysis.  
(n=123) 
Variable Yes No 
Diabetes 59(48%) 64 (52%) 
Hypertension 104(84.6%) 19(15.4%) 
Ischemic Heart disease 23(18.7%) 100(81.3%) 
Nephrolithiasis 5(4.1%) 118(95.9%) 
Peripheral vascular 
disease 
2(1.6%) 121(98.4%) 
Lung disease 2(1.6%) 121(98.4%) 
Cerebrovascular accident 3(2.4%) 120(97.6%) 
 
Table no. 2 
                                         Quality of life score with co-morbidity pattern. 
(n = 123)  
QOL° 
Domains 
Total 
(N=123) 
Diabetes 
(n=59) 
Hypertension 
(n=104) 
IHD° 
(n=23) 
CVA° 
(N=3) 
PVD° 
(N=2) 
LD° 
N=2 
Stone° 
N=5 
Physical 
Function 
49.92±30.90 48.69±28.52 49.13±30.82 36.30±27.18 40.00±35.00 17.50±10.60 47.50±31.82 58.00±46.44 
Role-
Physical 
38.82±41.39 30.52±38.58 34.86±39.63 29.35±38.17 00.00±00.00 12.50±17.67 00.00±00.00 45.00±54.19 
Body Pain 
46.73±26.54 43.80±24.38 44.68±26.17 49.87±27.57 51.00±44.84 100.00±00.00 58.00±22.62 35.40±8.76 
General 
Health 
40.52±21.65 37.66±21.60 39.43±21.93 32.91±21.70 18.33±17.55 56.00±29.69 26.00±15.55 53.80±28.50 
Vitality 43.98±21.82 40.17±22.76 42.79±21.70 32.39±22.04 15.00±15.00 40.00±14.14 45.00±7.07 50.00±25.45 
Social 
Function 
49.43±27.76 50.88±24.43 50.76±27.81 52.19±28.87 70.83±19.09 87.50±9.50 31.25±8.83 17.50±28.77 
Role 
emotional 
49.85±40.59 48.00±39.78 47.73±39.63 28.94±35.2 44.44±50.91 50.00±70.71 50.00±70.71 26.66±43.46 
Mental 
Health 
59.93±17.36 57.76±18.91 58.58±17.47 51.30±18.67 46.67±33.30 80.00±5.65 50.00±2.82 65.60±21.09 
°QOL;quality of life, IHD; ischemic heart disease, PVD; peripheral vascular disease, LD;Lung disease, Stone;Renal 
stone disease 
 
Discussion    
To measure dialysis adequacy, quality of life of CKD patients is a primary indicator for dialysis units. Mortality 
in patients on dialysis is influenced with health related quality of life.  The SF36, an established and a well-
recognized, scoring system to ascertain quality of life which has 8 different independent domains with two 
summary component being used all over the world and has already been validated. The main objective of the 
nephrologists is to enhance functional capabilities of dialysis patients so that they are more satisfied and can 
enjoy their living.  
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The results of our study have demonstrated that physical and mental health is affected in dialysis patients 
particularly those having co-morbidities like diabetes, hypertension, IHD etc. This leads to increase disease 
morbidity and exerts extra pressure on healthcare facilities in terms of occupying beds and more investments in 
health sector as well as by suffering the families. This increase in disease morbidity is not only restricted to the 
patient but also affects the life of their families in terms of psychological, social and economical stress. 
Moreover this disease hits main workforce of the society (in their middle ages) so it has great impact on national 
economy as well due to the disabilities and family income also suffers as they are more dependent on therapy to 
sustain their survival. Same findings have been reported in different studies done in different population subsets 
comparing their decreased functional well being with that of general population [9],[10] .We did not compare 
this with our healthy control subjects because it has already been proved by many studies. 
Chronic diseases such as Diabetes, PVD, hypertension etc have already been reported to have an influence on the 
quality of life of the patients. Although the spectrum of different co-morbidities differ from disease to disease as 
has been noticed in our study. Previous studies have already documented diabetes being a co-morbid disease of 
chronic kidney disease which results in very poor quality of life of these patients, these findings are in 
compliance with our study results [11], [12]. 
In our study, overall quality of life score was poor in patients with peripheral vascular disease, ischemic heart 
disease and cerebrovascular accident as it has been reported in other reports [13],[14]. Quality of life may be 
significantly compromised with increasing number of co-morbidites among targeted population [13].  
In all domains quality of life was poor in female populations as compared with male patients which constitute 52 
% of our total population of Pakistan. Although the root cause of this gender specific difference has not been 
defined clearly, however all the females had some degree of depression due to aesthetic appearance issues and 
economic dependency on their family members in our study. Similar results have been observed in many 
different studies reporting lower quality of life score in female patients than that of male patients. [15, 16, 17, 
22]. 
Anemia and hypoalbuminemia were very common in our study, again both these are associated with poor quality 
of life, this association with poor quality of life has been established in other studies as well. [18,19,20,21]. 
These findings emphasize the importance of early intervention for correction of these parameters, so that their 
negative effect on quality of life may be minimized.  
The major limitations of the current study were that it is single centre study and questionnaires were not self 
administered, due to language barrier it was interviewed as our major dialysis population education status were 
illiterate. 
Conclusion; The results of our study indicate that quality of life was poor among patients on hemodialysis 
particularly those having co-morbidities. Hypertension and diabetes were major co-morbidities in our study. 
Quality of life score was lower in female patients than that of male patients. Proper management of co-
morbidities can improve quality of life of these patients which will decrease disease morbidity and mortality. 
This will also provide psychological and financial relief to the suffering families and also be cost effective for 
hospital authorities in terms of availability of space.  
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